20/01/2021 9:10 am Welcome to isteroids.com - BLOG

Tuesday 22, Jun 2010

  Court urged to reverse ruling in Bonds Case

Posted By
Pin it Share on Tumblr

Court urged to reverse ruling in Bonds CaseA three-judge panel of a federal appeals court heard arguments from lawyers and prosecutors for Barry Bonds on whether the prosecutors should be allowed to use positive steroid drug tests as evidence at perjury trial of Bonds.

Bonds was indicated in 2007 on charges that he lied before a grand jury about his use of performance enhancing drugs during BALCO investigations.

Peter Keane, a professor at Golden Gate University School of Law, remarked that the government has a “stiff climb” since appeals courts are generally reluctant to overrule a trial judge ruling on evidence admissibility, especially before a trial.

Monday 22, Feb 2010

  MS drug and steroids can redefine treatment by reducing disease activity

Posted By
Pin it Share on Tumblr

MS drug and steroids can redefine treatment by reducing disease activityDisease activity related with multiple sclerosis (MS) is reduced to a considerable extent when a combination of steroid drugs and MS drug is administered to patients, as per a study presented as a part of the Late-breaking Science Program at the American Academy of Neurology’s 61st Annual Meeting in Seattle.

Study author Mads Ravnborg, MD, of the Danish Multiple Sclerosis Research Center at Copenhagen University Hospital in Denmark, said that the study noted that both the drugs seem to have a synergy when taken together for providing improved beneficial effect on the disease activity as against use of the MS drug in isolation.

Friday 29, Jan 2010

  Steroid drug addition to MS treatment effective for reducing disease activity

Posted By
Pin it Share on Tumblr

Steroid drug addition to MS treatment effective for reducing disease activityThe use of a steroid drug, methylprednisolone, in addition to a multiple sclerosis (MS) drug can prove to be a more effective combination for reducing the volume of disease activity than the use of MS drug alone.

This finding was presented as part of the Late-breaking Science Program at the American Academy of Neurology’s 61st Annual Meeting in Seattle, April 25 – May 2, 2009.

Study author Mads Ravnborg, MD, of the Danish Multiple Sclerosis Research Center at Copenhagen University Hospital in Denmark, remarked that the results suggest that both drugs seem to have a synergy when taken as a combination and offer a more beneficial effect on the disease activity.

Monday 14, Dec 2009

  Steroid drugs added to MS treatment can reduce disease activity

Posted By
Pin it Share on Tumblr

Steroid drugs added to MS treatment can reduce disease activityThe addition of a steroid drug, methylprednisolone, to the multiple sclerosis (MS) drug can significantly reduce the amount of disease activity more than what could have been experienced with the use of MS drug in isolation, as per a presented study as part of the Late-breaking Science Program at the American Academy of Neurology’s 61st Annual Meeting in Seattle.

The study results clearly suggest that the two drugs, steroid and MS, can bring synergy when taken as a combination and provide a greater beneficial effect on the disease activity than MS drug alone, according to study author Mads Ravnborg, MD, of the Danish Multiple Sclerosis Research Center at Copenhagen University Hospital in Denmark.

 

 

 



Monday 30, Nov 2009

  Addition of steroids drugs to MS treatment can reduce disease activity

Posted By
Pin it Share on Tumblr

Addition of steroids drugs to MS treatment can reduce disease activity  When steroid drugs are added to multiple sclerosis (MS) treatment, the risk of disease activity gets reduced to a considerable extent as per a study presented as a part of the Late-breaking Science Program at the American Academy of Neurology’s 61st Annual Meeting in Seattle.

It was remarked by study author Mads Ravnborg, MD, of the Danish Multiple Sclerosis Research Center at Copenhagen University Hospital in Denmark, that results of this study highlight the fact that the two drugs tend to bring synergy in a combination and provide an improved beneficial effect on the disease activity as against use of the MS drug in isolation.

 


Thursday 21, May 2009

  Steroids and MS Drugs to treat Multiple Sclerosis

Posted By
Pin it Share on Tumblr

Steroids and MS Drugs to treat Multiple SclerosisAs per a recently concluded study, a combination of steroids and multiple sclerosis (MS) drugs to treat MS can minimize the amount of disease activity more than a MS drug alone. This study was a part of the Late-breaking Science Program at the American Academy of Neurology’s 61st Annual Meeting that was conducted in Seattle, Washington from April 25 – May 2, 2009.

Multiple Sclerosis, also known as encephalomyelitis disseminata, is an autoimmune condition in which the human body’s immune system poses an attack to the central nervous system. Such an attack leads to demyelination (damage of myelin sheath of neurons). Impairments of movement, cognition, and sensation are some of the possible ailments after a demyelinating disease.

This means that the steroid drug methylprednisolone can now be used as an ongoing treatment along with being used to treat acute MS attacks. The above statements also suggest that a combination of steroids and multiple sclerosis (MS) drugs to treat MS offers a more beneficial effect on the disease activity than what can be offered by a MS drug alone.

These findings are expected to offer a sigh of relief to all those patients who were fighting a lone battle against Multiple Sclerosis.

Monday 04, May 2009

  Steroid Drug Methylprednisolone Can Treat Multiple Sclerosis

Posted By
Pin it Share on Tumblr

Steroid Drug Methylprednisolone Can Treat Multiple SclerosisFindings from a study recently announced that a steroid drug can now be used to treat multiple sclerosis (MS) in addition to the usually prescribed MS drugs. This finding was part of the Late-breaking Science Program at the American Academy of Neurology’s 61st Annual Meeting in Seattle, held in April 25 – May 2, 2009.

In the study, 341 people with relapsing-remitting multiple sclerosis (MS) participated. Half of the participants were given both steroid drug methylprednisolone, plus the regular weekly treatment with the drug interferon beta-1a. Meanwhile, the other 50% of the participants were administered with the interferon drug plus a placebo. The participants who were administered with both drugs had 38 percent fewer relapses than those who were only given interferon drug.

These results showed that interfon work only moderate and not everyone responds fully to the treatment, but when combined with steroid drug methylprednisolone, more beneficial effects of controlling multiple sclerosis attacks.